Melita Jung
Corporate Officer/Principal presso TERNS PHARMACEUTICALS, INC.
Patrimonio netto: - $ in data 31/05/2024
Posizioni attive di Melita Jung
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 22/04/2024 | - |
Storia della carriera di Melita Jung
Precedenti posizioni note di Melita Jung
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/07/2017 | 01/01/2021 |
| ADAMAS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/07/2014 | 01/06/2017 |
Ascendancy Healthcare, Inc.
 Ascendancy Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Ascendancy Healthcare, Inc. engages in the commercialization of pharmaceutical productS. It enables product entry by providing clinical, regulatory and commercial expertise and oversight along with funding. The company was founded by Arthur Joseph Higgins and Sanford S. Zweifach on November 21, 2011 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01/04/2012 | 01/05/2014 |
| STRUCTURE THERAPEUTICS INC. | Corporate Officer/Principal | 01/05/2021 | - |
Formazione di Melita Jung
| University of California, Berkeley | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Corporate Officer/Principal | 5 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| STRUCTURE THERAPEUTICS INC. | Commercial Services |
| TERNS PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Ascendancy Healthcare, Inc.
Ascendancy Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Ascendancy Healthcare, Inc. engages in the commercialization of pharmaceutical productS. It enables product entry by providing clinical, regulatory and commercial expertise and oversight along with funding. The company was founded by Arthur Joseph Higgins and Sanford S. Zweifach on November 21, 2011 and is headquartered in San Francisco, CA. | Health Technology |
Adamas Pharmaceuticals LLC
 Adamas Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Adamas Pharmaceuticals, Inc. engages in discovery and development of chrono-synchronous therapies for chronic neurologic disorders. Its products include GOCOVRI, ADS-5012, ADS-4101, and Namzaric. GOCOVRI is indicated for the treatment of dyskinesia in patients with Parkinson’s disease receiving levodopa-based therapy. ADS-5102 is a treatment for walking impairment in patients with multiple sclerosis. ADS-401 treats partial onset seizures in patients with epilepsy. Namzaric is a drug treatment for moderate to severe Alzheimer's disease. The company was founded by Gregory T. Went on November 15, 2000 and is headquartered in Emeryville, CA. | Health Technology |
- Borsa valori
- Insiders
- Melita Jung
- Esperienza
